| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
104.63(B) |
| Last
Volume: |
8,786,292 |
Avg
Vol: |
8,469,733 |
| 52
Week Range: |
$48.64 - $73.26 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
69 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nicholas Peter M |
Director |
– • – |
2012-03-15 |
4 |
AS |
$0.00 |
$0 |
I/I |
(18,600) |
3,512,421 |
|
- |
|
| Abele John E |
Director Emeritus |
– – – |
2012-03-15 |
4 |
AS |
$0.00 |
$0 |
D/D |
(490,000) |
11,322,718 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$7,041 |
D/D |
(1,107) |
10,800 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,492 |
11,907 |
|
- |
|
| Pucel Kenneth |
EVP, Global Ops & Technology |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$21,789 |
D/D |
(3,426) |
107,197 |
|
- |
|
| Pucel Kenneth |
EVP, Global Ops & Technology |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
110,623 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$21,122 |
D/D |
(3,321) |
81,792 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
85,113 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$16,899 |
D/D |
(2,657) |
58,012 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,380 |
60,669 |
|
- |
|
| Spriggs Otha T. Iii |
SVP, Human Resources |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$10,367 |
D/D |
(1,630) |
7,822 |
|
- |
|
| Spriggs Otha T. Iii |
SVP, Human Resources |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,540 |
9,452 |
|
- |
|
| Neumann Lawrence R |
SVP, Special Projects |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$10,564 |
D/D |
(1,661) |
77,000 |
|
- |
|
| Neumann Lawrence R |
SVP, Special Projects |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,238 |
78,661 |
|
- |
|
| Onuscheck John Michael |
SVP & President, EMEA |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$14,577 |
D/D |
(2,292) |
53,843 |
|
- |
|
| Onuscheck John Michael |
SVP & President, EMEA |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,238 |
56,135 |
|
- |
|
| Kucheman William |
Chief Executive Officer |
• • – |
2012-02-28 |
4 |
D |
$6.36 |
$28,162 |
D/D |
(4,428) |
102,525 |
|
- |
|
| Kucheman William |
Chief Executive Officer |
• • – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,967 |
106,953 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$8,720 |
D/D |
(1,371) |
72,075 |
|
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,190 |
73,446 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$21,122 |
D/D |
(3,321) |
128,805 |
|
- |
|
| Capello Jeffrey D |
EVP & Chief Financial Officer |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,475 |
132,126 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$9,858 |
D/D |
(1,550) |
61,965 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,889 |
63,515 |
|
- |
|
| Burns Brian R |
EVP - Global Quality & Reg Aff |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$15,493 |
D/D |
(2,436) |
79,418 |
|
- |
|
1831 Records found
|
|
Page 20 of 74 |
|
|
0.09 (0.12%) 
